Martin Johnson

1.9k total citations
30 papers, 1.3k citations indexed

About

Martin Johnson is a scholar working on Pediatrics, Perinatology and Child Health, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Martin Johnson has authored 30 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pediatrics, Perinatology and Child Health, 15 papers in Psychiatry and Mental health and 9 papers in Pharmacology. Recurrent topics in Martin Johnson's work include Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Neuroscience and Neuropharmacology Research (9 papers). Martin Johnson is often cited by papers focused on Epilepsy research and treatment (13 papers), Pharmacological Effects and Toxicity Studies (12 papers) and Neuroscience and Neuropharmacology Research (9 papers). Martin Johnson collaborates with scholars based in United States, United Kingdom and France. Martin Johnson's co-authors include Sarah Lu, Wim Van Paesschen, John Whitesides, Philippe Ryvlin, Konrad J. Werhahn, Barbara Błaszczyk, Michael R. Sperling, Bassel Abou‐Khalil, Samuel F. Berkovic and Victor Biton and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Martin Johnson

30 papers receiving 1.3k citations

Peers

Countries citing papers authored by Martin Johnson

Since Specialization

Citations

This map shows the geographic impact of Martin Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Johnson more than expected).

Fields of papers citing papers by Martin Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Johnson. The network helps show where Martin Johnson may publish in the future.

Co-authorship network of co-authors of Martin Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Johnson. A scholar is included among the top collaborators of Martin Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Johnson. Martin Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The development of a nurse-led preoperative anaesthesia screening tool by Delphi consensus 2024 ·South African Medical Journal ·M Nejthardt, (unknown), Sudha Bechan, (unknown), S Chetty, (unknown), (unknown), Martin Johnson, Hyla‐Louise Kluyts, Richard Llewellyn, (unknown), (unknown), (unknown), Busisiwe Mrara, F Roodt, (unknown), Sandra Spijkerman, Edwin Turton, (unknown), Bruce Biccard	1
2	Tolerability, safety, and efficacy of adjunctive brivaracetam for focal seizures in older patients: A pooled analysis from three phase III studies 2016 ·Epilepsy Research ·Martin J. Brodie, John Whitesides, Jimmy Schiemann, Joseph D’Souza, Martin Johnson	29
3	Laxatives Do Not Improve Symptoms of Opioid-Induced Constipation: Results of a Patient Survey 2016 ·Pain Medicine ·Anton Emmanuel, Martin Johnson, Paula McSkimming, Sara Dickerson	39
4	Safety, tolerability, and seizure control during long‐term treatment with adjunctive brivaracetam for partial‐onset seizures 2016 ·Epilepsia ·Manuel Toledo, John Whitesides, Jimmy Schiemann, Martin Johnson, Klaus Eckhardt, (unknown), Simon Borghs, Patrick Kwan	60
5	Post Hoc Analysis of Time to Sustained 50[percnt] Responder Status in Three Phase III Studies of Brivaracetam (BRV) as Adjunctive Treatment for Partial-Onset (Focal) Seizures (POS) (P2.036) 2016 ·Neurology ·Pavel Klein, Martin Johnson, Jimmy Schiemann, John Whitesides	1
6	Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies 2016 ·Neurology ·Elinor Ben‐Menachem, Rūta Mameniškienė, Pier Paolo Quarato, Pavel Klein, (unknown), Jimmy Schiemann, Martin Johnson, John Whitesides, (unknown), Klaus Eckhardt	94
7	Phase I, double-blind, placebo-controlled, ascending single subcutaneous dose, safety, tolerability, and pharmacokinetic study of sustained release granisetron (APF530). 2013 ·Journal of Clinical Oncology ·John Barr, (unknown), Martin Johnson	1
8	Brivaracetam as adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double‐blind, placebo‐controlled trial 2013 ·Epilepsia ·Victor Biton, Samuel F. Berkovic, Bassel Abou‐Khalil, Michael R. Sperling, Martin Johnson, Sarah Lu	208
9	Assessment and Management of Neuropathic Pain in Primary Care 2012 ·Pain Management ·Blair H. Smith, Nicola Torrance, Martin Johnson	7
10	Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial‐onset seizures: A phase IIb, randomized, controlled trial 2012 ·Epilepsia ·Wim Van Paesschen, Édouard Hirsch, Martin Johnson, Ursula Falter, Philipp von Rosenstiel	117
11	Education as part of wider health policy and improvement strategies 2012 ·British Journal of Pain ·Benjamin Ellis, Martin Johnson, Ann Taylor	5
12	Persistent pain: not a medically unexplained symptom 2011 ·British Journal of General Practice ·Amanda C de C Williams, Martin Johnson	7
13	Cancer Pain: Part 1: Pathophysiology; Oncological, Pharmacological, and Psychological Treatments: A Perspective from the British Pain Society Endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners 2010 ·Pain Medicine ·Jon H. Raphael, Sam H. Ahmedzai, Joan Hester, Catherine Urch, (unknown), John E. Williams, Paul Farquhar-Smith, Marie Fallon, Peter Hoskin, Karen Robb, Mike Bennett, (unknown), Martin Johnson, Arun Bhaskar, Sam Chong, Rui Duarte, Elizabeth Sparkes	84
14	Intravenous lacosamide as short‐term replacement for oral lacosamide in partial‐onset seizures 2009 ·Epilepsia ·Gregory L. Krauss, Elinor Ben‐Menachem, Rūta Mameniškienė, Nerija Vaičienė-Magistris, Melissa Brock, John Whitesides, Martin Johnson	63
15	Do strong opioids have a role in the early management of back pain? Recommendations from a European expert panel 2005 ·Current Medical Research and Opinion ·Eija Kalso, L. Allan, Jan Dobrogowski, Martin Johnson, Nevenka Krcevski‐Škvarč, Gary J. Macfarlane, Gérard Mick, S. Ortolani, Serge Perrot, (unknown), (unknown), Jan Sörensen	25
16	Chronic pain management -can we do better? An interview-based survey in primary care 2003 ·Current Medical Research and Opinion ·Cathy Stannard, Martin Johnson	47
17	Patients Have Treatment Preferences: A Multicentre, Double-blind, Crossover Study Comparing Rabeprazole and Omeprazole 2002 ·Current Medical Research and Opinion ·Martin Johnson, (unknown), Susan E. Libretto	10
18	Multiple-Dose Pharmacokinetics and Tolerability of Gemifloxacin Administered Orally to Healthy Volunteers 2001 ·Antimicrobial Agents and Chemotherapy ·Ann Allen, (unknown), (unknown), Stuart Oliver, Martin Johnson, Chris Ward, (unknown), (unknown), (unknown)	27
19	Insulin lispro in the treatment of patients with type 2 diabetes mellitus after oral agent failure 1999 ·Clinical Therapeutics ·Edward J. Bastyr, Martin Johnson, Michael Trautmann, James H. Anderson, Louis Vignati	43
20	Comparison of intranasal versus intravenous verapamil bioavailability. 1993 ·PubMed ·Sharon Watling, Jeffery A. Engelhardt, (unknown), (unknown), Patricia D. Kroboth, Harold T. Smith, Martin Johnson	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact